442 related articles for article (PubMed ID: 1284179)
1. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
[TBL] [Abstract][Full Text] [Related]
2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.
Chintu C; Luo C; Bhat G; Raviglione M; DuPont H; Zumla A
Arch Dis Child; 1993 May; 68(5):665-8. PubMed ID: 7686737
[TBL] [Abstract][Full Text] [Related]
5. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.
Lawn SD; Frimpong EH; Acheampong JW
West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785
[TBL] [Abstract][Full Text] [Related]
6. Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania.
Ipuge YA; Rieder HL; Enarson DA
Lancet; 1995 Sep; 346(8976):657-60. PubMed ID: 7544858
[TBL] [Abstract][Full Text] [Related]
7. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS.
Salami TA; Asalu AF; Samuel SO
Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333
[TBL] [Abstract][Full Text] [Related]
10. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; RĂ¼sch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases.
Wirima JJ; Harries AD
East Afr Med J; 1991 Jan; 68(1):64-6. PubMed ID: 2060484
[TBL] [Abstract][Full Text] [Related]
13. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
[TBL] [Abstract][Full Text] [Related]
16. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
Okwera A; Whalen C; Byekwaso F; Vjecha M; Johnson J; Huebner R; Mugerwa R; Ellner J
Lancet; 1994 Nov; 344(8933):1323-8. PubMed ID: 7526098
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis.
Gupta PK; Luniya AK; Gupta NK; Tiwari ML
Indian J Chest Dis Allied Sci; 1983; 25(2):152-4. PubMed ID: 6197367
[No Abstract] [Full Text] [Related]
18. [Cutaneous reactions to thiacetazone (TB1) (author's transl)].
Strobel M; Ndiaye B; Marchand JP; Jovet JC
Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis of the spine in children at Muhimbili Medical Centre, Dar es Salaam.
Sayi EN; Mlay SM
East Afr Med J; 1995 Jan; 72(1):46-8. PubMed ID: 7781556
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic review: tuberculosis.
Houston S; Pozniak A; Ray CS
Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]